LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 88.84 | 27.76 | 2156 | 6965 | 0.3096 | 0.7264 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 88.84 | 27.76 | 40 | 6965 | 0.0057 | 0.0469 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 88.84 | 27.76 | 2632 | 6965 | 0.3779 | 0.7701 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 90.55 | 27.76 | 13 | 6928 | 0.0019 | -0.0909 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 90.55 | 27.76 | 2142 | 6928 | 0.3092 | 0.7259 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 90.55 | 27.76 | 33 | 6928 | 0.0048 | 0.0220 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 90.55 | 27.76 | 2660 | 6928 | 0.3839 | 0.7735 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 92.25 | 27.76 | 10 | 6873 | 0.0015 | -0.1205 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 92.25 | 27.76 | 2134 | 6873 | 0.3105 | 0.7264 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 92.25 | 27.76 | 26 | 6873 | 0.0038 | -0.0082 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 92.25 | 27.76 | 2611 | 6873 | 0.3799 | 0.7708 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 93.96 | 27.76 | 6 | 6849 | 0.0009 | -0.1753 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 93.96 | 27.76 | 2130 | 6849 | 0.3110 | 0.7266 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 93.96 | 27.76 | 25 | 6849 | 0.0037 | -0.0131 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 93.96 | 27.76 | 2608 | 6849 | 0.3808 | 0.7712 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 95.66 | 27.76 | 5 | 6712 | 0.0007 | -0.1947 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 95.66 | 27.76 | 2041 | 6712 | 0.3041 | 0.7208 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 95.66 | 27.76 | 21 | 6712 | 0.0031 | -0.0346 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 95.66 | 27.76 | 2465 | 6712 | 0.3672 | 0.7623 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 1.95 | 27.76 | 410 | 225 | 1.8211 | 1.4391 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 1.95 | 27.76 | 615 | 225 | 2.7316 | 1.7896 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 3.66 | 27.76 | 538 | 283 | 1.8948 | 1.4198 | MN20160318_Q01 | H17 |